KR101602552B1 - Antimicrobial composition comprising the extract of cornus officinalis - Google Patents
Antimicrobial composition comprising the extract of cornus officinalis Download PDFInfo
- Publication number
- KR101602552B1 KR101602552B1 KR1020140028383A KR20140028383A KR101602552B1 KR 101602552 B1 KR101602552 B1 KR 101602552B1 KR 1020140028383 A KR1020140028383 A KR 1020140028383A KR 20140028383 A KR20140028383 A KR 20140028383A KR 101602552 B1 KR101602552 B1 KR 101602552B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- corn oil
- ethyl acetate
- fraction
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 93
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 63
- 239000000203 mixture Substances 0.000 title claims abstract description 62
- 241000759833 Cornus officinalis Species 0.000 title claims description 11
- 230000036541 health Effects 0.000 claims abstract description 16
- 239000004599 antimicrobial Substances 0.000 claims abstract description 15
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 15
- 235000013376 functional food Nutrition 0.000 claims abstract description 13
- 239000000490 cosmetic additive Substances 0.000 claims abstract description 3
- 239000002778 food additive Substances 0.000 claims abstract description 3
- 239000003674 animal food additive Substances 0.000 claims abstract 2
- 239000002038 ethyl acetate fraction Substances 0.000 claims description 33
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 claims description 24
- 239000003599 detergent Substances 0.000 claims description 19
- 239000002044 hexane fraction Substances 0.000 claims description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
- 208000035143 Bacterial infection Diseases 0.000 claims description 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 4
- 235000013373 food additive Nutrition 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 abstract description 67
- 239000002285 corn oil Substances 0.000 abstract description 67
- 239000000469 ethanolic extract Substances 0.000 abstract description 39
- 235000013305 food Nutrition 0.000 abstract description 23
- 241001465754 Metazoa Species 0.000 abstract description 17
- 239000002537 cosmetic Substances 0.000 abstract description 17
- 239000003921 oil Substances 0.000 abstract description 15
- 235000019198 oils Nutrition 0.000 abstract description 15
- 239000000843 powder Substances 0.000 abstract description 13
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 12
- 239000003960 organic solvent Substances 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 229940121375 antifungal agent Drugs 0.000 abstract description 6
- 230000000843 anti-fungal effect Effects 0.000 abstract description 5
- 230000002378 acidificating effect Effects 0.000 abstract description 4
- 239000006071 cream Substances 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- -1 ring Substances 0.000 abstract description 3
- 239000012871 anti-fungal composition Substances 0.000 abstract description 2
- 235000013336 milk Nutrition 0.000 abstract description 2
- 239000008267 milk Substances 0.000 abstract description 2
- 210000004080 milk Anatomy 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 72
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 28
- 150000008442 polyphenolic compounds Chemical class 0.000 description 20
- 235000013824 polyphenols Nutrition 0.000 description 20
- 239000002034 butanolic fraction Substances 0.000 description 18
- 239000000654 additive Substances 0.000 description 16
- 229940093499 ethyl acetate Drugs 0.000 description 16
- 235000019439 ethyl acetate Nutrition 0.000 description 16
- 238000000605 extraction Methods 0.000 description 16
- 229930003935 flavonoid Natural products 0.000 description 15
- 150000002215 flavonoids Chemical class 0.000 description 15
- 235000017173 flavonoids Nutrition 0.000 description 15
- 230000002949 hemolytic effect Effects 0.000 description 15
- 235000000346 sugar Nutrition 0.000 description 15
- 241000282414 Homo sapiens Species 0.000 description 14
- 239000004480 active ingredient Substances 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 230000009036 growth inhibition Effects 0.000 description 10
- 241000233866 Fungi Species 0.000 description 9
- 210000003743 erythrocyte Anatomy 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 description 9
- 230000000996 additive effect Effects 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 241000222122 Candida albicans Species 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 241000192125 Firmicutes Species 0.000 description 5
- CWNKMHIETKEBCA-UHFFFAOYSA-N alpha-Ethylaminohexanophenone Chemical compound CCCCC(NCC)C(=O)C1=CC=CC=C1 CWNKMHIETKEBCA-UHFFFAOYSA-N 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 239000010779 crude oil Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 238000005194 fractionation Methods 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000186779 Listeria monocytogenes Species 0.000 description 4
- 241000588767 Proteus vulgaris Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 239000013504 Triton X-100 Substances 0.000 description 4
- 229920004890 Triton X-100 Polymers 0.000 description 4
- 235000019730 animal feed additive Nutrition 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 239000003429 antifungal agent Substances 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000012459 cleaning agent Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229960001031 glucose Drugs 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229940007042 proteus vulgaris Drugs 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 241000238557 Decapoda Species 0.000 description 3
- 241000258955 Echinodermata Species 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- RYPKRALMXUUNKS-UHFFFAOYSA-N 2-Hexene Natural products CCCC=CC RYPKRALMXUUNKS-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 230000003178 anti-diabetic effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- UMYJVVZWBKIXQQ-QALSDZMNSA-N (4aS,6aR,6bR,8aR,12aR,12bR,14aS)-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a-icosahydropicene-4a-carboxylic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C=C5[C@H]4CC[C@@H]3[C@]21C UMYJVVZWBKIXQQ-QALSDZMNSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 239000001188 FEMA 4487 Substances 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000276457 Gadidae Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- UMYJVVZWBKIXQQ-UHFFFAOYSA-N Moronic acid Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)C=C5C4CCC3C21C UMYJVVZWBKIXQQ-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000269908 Platichthys flesus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 235000020167 acidified milk Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000037815 bloodstream infection Diseases 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 239000002031 ethanolic fraction Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 244000078673 foodborn pathogen Species 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000009083 hemolysis by symbiont of host erythrocytes Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000000185 intracerebroventricular administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 산수유 추출물을 포함하는 항균 조성물로서, 보다 상세하게는 산수유의 열수 또는 에탄올 추출물 및 이의 유기용매 분획물을 포함하는 항세균 및 항진균 조성물에 관한 것이다. 본 발명의 산수유 추출물 및 분획물은 우수한 항균 활성을 나타내어, 항세균 및/또는 항진균용 약학 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품, 화장품 또는 동물 사료용 첨가물, 및 각종 청결제 등의 용도로 사용할 수 있는 뛰어난 효과가 있다. 뿐만 아니라, 본 발명의 산수유 추출물 및 분획물은 열 안정성이 우수하고, pH 2의 산성조건 및 혈장 내에서도 활성의 손실이 나타나지 않아, 액상, 크림, 분말, 환, 정 등의 다양한 형태로 손쉽게 가공될 수 있어 제약 산업, 식품 산업, 축산업, 보건 산업 및 화장품 산업상 매우 유용하게 이용될 수 있다.The present invention relates to an antimicrobial composition comprising a corn oil extract, and more particularly to an antimicrobial and antifungal composition comprising a hydrothermal or ethanol extract of corn oil and an organic solvent fraction thereof. The extract of marine oil of the present invention exhibits an excellent antibacterial activity and is useful as an antibacterial and / or antifungal pharmaceutical composition, a health functional food, a cosmetic composition, an animal feed composition, food, cosmetic or animal food additive, There is an excellent effect that can be used. In addition, the acidic milk extract and fractions of the present invention are excellent in thermal stability and can be easily processed into various forms such as liquid, cream, powder, ring, and tablet without showing loss of activity even in an acidic condition of pH 2 and plasma It can be very useful in pharmaceutical industry, food industry, animal husbandry industry, health industry and cosmetics industry.
Description
본 발명은 산수유 추출물을 포함하는 항균 조성물로서, 보다 상세하게는 산수유의 열수 또는 에탄올 추출물 및 이의 유기용매 분획물을 포함하는 항세균 및 항진균 조성물에 관한 것이다.The present invention relates to an antimicrobial composition comprising a corn oil extract, and more particularly to an antimicrobial and antifungal composition comprising a hydrothermal or ethanol extract of corn oil and an organic solvent fraction thereof.
미국 질병관리예방센터(U.S. Center for Disease Control and Prevention)에 따르면, 병원 내 혈류 감염이 미국에서 주된 사망 원인 중 하나이다. 또한, 피부 및 연조직을 통한 병원성 세균 및 진균의 감염은 보편적인 의학적 질병으로 인식되어 있으며, 주로 외상 또는 수술에 의하여 유발되는 것으로 이해되고 있다. 많은 병원성 세균 및 진균의 감염은 감염의 중증도에 따라 그 처치 방법이 다르지만, 경구용 항미생물제 및 국소 청결로 성공적인 치료가 가능하다. 그러나, 근원적인 위험 인자(예를 들면, 혈관 혈류이상, 당뇨) 및/또는 치료하기 어렵거나 다중-내성인 세균 및 진균에 의해 유발된 감염을 갖는 환자에서 흔히 발생하는 보다 심하거나 복잡한 감염은 정맥 내 항미생물제 치료 및 침입성 외과적 조직제거 등의 조치가 필요할 수도 있다. 실례로, 글라이코펩타이드계 항생물질인 반코마이신은 다중-약물-내성 그램-양성균, 특히 MRSA, 응고효소-음성 스태필로코커스 및 엔테로코커스에 의해 야기된 심한 병원 내 감염에 대해 성공적으로 사용되어왔다. 그러나 최근 반코마이신에 대해 내성을 갖는 균주의 분리가 증가하고 있음이 보고되고 있으며, 현재의 항생제로는 병원균 중 일부균에 의해 유발된 심한 감염에 대한 치료가 매우 제한되어 있는 것이 사실이다. 따라서 점차 증가되고 있는 내성균에 대한 보다 효과적인 새로운 항생물질 개발의 필요성이 증가되고 있다.According to the U.S. Center for Disease Control and Prevention, bloodstream infections in hospitals are one of the leading causes of death in the United States. Infections of pathogenic bacteria and fungi through skin and soft tissues are also recognized as universal medical diseases and are mainly caused by trauma or surgery. Many pathogenic bacterial and fungal infections are treated differently depending on the severity of the infection, but successful treatment is possible with oral antimicrobials and topical cleansing. However, the more severe or complex infections that are common in patients with underlying risk factors (e. G., Vascular flow disorders, diabetes) and / or infections caused by difficult or multi-resistant bacilli and fungi, Treatment with antimicrobial agents and removal of invasive surgical tissue may be required. For example, vancomycin, a glycopeptide antibiotic, has been successfully used for severe intra-hospital infections caused by multi-drug-resistant gram-positive bacteria, particularly MRSA, coagulase-negative staphylococcus and enterococcus. Recently, it has been reported that the isolation of strains resistant to vancomycin is increasing, and the current antibiotics are very limited in the treatment of severe infections caused by some of the pathogens. Therefore, there is a growing need for more effective new antibiotics for resistant bacteria.
한편, 산수유(Cornus officinalis)는 층층나무과(Comaceae)에 속하는 약용식물로 그 열매는 길이 1.5cm 내외의 중추원형의 모양이며, 신맛이 두드러져 촉산초라고도 불리며, 자양강장 효과를 가진 천연식품으로 널리 이용하고 있다. 현재 시중에 유통되고 있는 산수유 관련 제품들은 씨를 제거한 찐 산수유를 건조한 건조제품과 산수유를 이용한 추출 액상음료 및 산수유분말을 이용한 환 형태의 제품이 대부분이며, 산수유 종자와 잎은 현재까지 대한민국 식품공전상 식품원재료로 등록되어 있지 않아, 식품으로 사용하기에는 제약이 있으며, 특이한 용도가 없이 폐기되고 있는 실정이다.Meanwhile, Cornus officinalis ) is a medicinal plant belonging to the Comaceae family. Its fruit is in the shape of a central circle around 1.5cm in length. It is also known as a succulent herb, which is prominent in sour taste, and is widely used as a natural food having a nourishing tonic effect. Most of the commercially available products of corn oil, which are currently sold in the market, are dried products with steamed corn oil removed from the seeds, extract liquid beverages with corn oil and corn oil with powder of corn oil, and corn oil seeds and leaves have been used as food It is not registered as a raw material, and there is a restriction to use it as a food.
따라서, 산수유의 경우 주로 과육에 대해 성분 및 효능연구가 진행되어 왔다. 산수유 과육에는 결정성 유기산, 몰식자산, 사과산, 포도주산 등이 있으며, 모르로니시드, 로가닌 등 이리도이드 배당체가 알려져 있고, 민간에 알려진 효능으로는 이뇨작용, 혈압강화작용, 항균작용, 간보호 작용이 있으며, 한방에서는 자양강장, 수렴약으로 콩팥을 보하며, 땀을 자주 흐리고, 오줌이 조금씩 자주 나올 때 사용하고 있다. 그러나, 현재까지 산수유 종자의 경우 산수유 종자의 독성과 렉틴성분(정시련 등, 1993, 한국약학회지, 24: 177-182), 산수유 종자의 항당뇨 효과(박영경 등, 1995, Chuna-ang J. Pharm. Sci. 9:5-11) 및 산수유 종자에서 당화산물 생성저해 활성성분에 대한 연구(Lee, G. Y et al., 2008, J. Kor. Soc. Appl. Biol. Chem. 51: 316-320)에 대한 보고가 알려진 바 있으나, 항당뇨 이외의 생리활성은 알려진 바 없으며, 특히, 산수유 종자 또는 잎의 항균 활성에 대해서는 보고된 바 없다.Therefore, in the case of corn oil, the components and efficacy researches have been conducted mainly on the pulp. It is known that iridoid glycosides such as moronic acid and roganin are known, and the effects known in the private sector include diuretic action, blood pressure strengthening action, antibacterial action, liver protection In one room, the kidneys are seen in the kidneys and the convergent medicine, sweating frequently, and when the urine frequently comes out often. However, up to now, the antidiabetic effects of corn oil seeds (Park, Yeong-gyung, 1995, Chuna-ang J. Pharm (1995) (1995), pp. 219-222). Inhibition of glycation endogenesis in seeds and seeds of marine algae (Lee, G. Y et al., 2008, J. Kor. Soc. 320), but no other biologic activity other than antidiabetic activity is known. In particular, no antimicrobial activity has been reported for the seeds or leaves of corn oil.
또한, 산수유와 관련된 특허로는 등록번호 제10-1358203호(2014-01-27)로서 [산수유 추출물을 함유하는 혈전증 예방 또는 치료용 조성물], 등록번호 제10-1330687호(2013-11-12)로서 [한약재의 추출물을 유효성분으로 포함하는 비만 예방 및 치료용 조성물], 등록번호 제10-1330688호(2013-11-12)로서 [한약재의 추출물을 유효성분으로 포함하는 당뇨병 전증 및 당뇨병의 예방 및 치료용 조성물], 등록번호 제10-0928711호(2009-11-19)로서 [산수유를 주재로 한 보양식품의 제조방법], 등록번호 제10-0438417호(2004-06-22)로서 [산수유를 주재로 한 건강식품의 제조방법], 등록번호 제10-1319984호(2013-10-14)로서 [항산화 활성을 증가시킨 산수유 발효 추출물의 제조방법] 등이 개시되어 있으나, 산수유 종자 또는 잎 관련 특허는 현재까지 알려진 바 없다. As a patent related to corn oil, it is disclosed in Korean Patent Registration No. 10-1358203 (2014-01-27) [composition for preventing or treating thrombosis containing crude oil extract], Registration No. 10-1330687 (2013-11-12 ) As a composition for prevention and treatment of obesity comprising an extract of a medicinal herb as an active ingredient, Registration No. 10-1330688 (2013-11-12) [containing an extract of a medicinal herb as an active ingredient for prevention of diabetes and diabetes As a composition for prevention and treatment], Registration No. 10-0928711 (2009-11-19), [Method for preparing a preserved food based on marine oil], Registration No. 10-0438417 (2004-06-22) [Method for producing fermented acid fermented milk with increased antioxidant activity] and the like have been disclosed as a method for producing health food based on corn oil, and Registration No. 10-1319984 (2013-10-14). However, Leaf-related patents are not known to date.
이에 본 발명자들은 의약품 소재, 건강기능식품 및 화장품 등 다양한 용도로 사용 가능한 신규의 항균 활성을 갖는 천연물 소재를 탐색하던 중, 산수유 종자 또는 잎의 추출물 및 분획물에서 강력한 항균 활성을 확인하였다. 이에, 본 발명자들은 다양한 용매로 산수유 종자 또는 잎 추출물을 조제한 후 순차적 유기용매 분획물을 조제하였으며, 이들 추출물 및 분획물의 강력한 항균 활성을 확인하여 본 발명을 완성하였다.Accordingly, the present inventors have found strong antimicrobial activity in extracts and fractions of corn oil seeds or leaves while searching for natural materials having antimicrobial activity that can be used for various purposes such as pharmaceutical materials, health functional foods and cosmetics. Accordingly, the present inventors prepared sequential organic solvent fractions after preparing seed oil or leaf extracts with various solvents, and confirmed the strong antibacterial activity of these extracts and fractions, thereby completing the present invention.
따라서, 본 발명에서 해결하고자 하는 과제는 산수유, 특히 산수유의 종자 또는 잎으로부터 항균 활성물질을 추출하여 분리 정제하고, 이를 유효성분으로 하는 항균 조성물을 제공하고자 하는 것이다.Accordingly, an object to be solved by the present invention is to provide an antimicrobial composition comprising an antimicrobial active substance extracted from marine oil, in particular, a seed or leaf of marine oil, followed by separation and purification, as an effective ingredient.
상기와 같은 과제를 해결하기 위하여, 본 발명은 산수유(Cornus officinalis) 추출물을 유효성분으로 함유하는 항균 조성물을 제공한다.In order to solve the above problems, the present invention provides an antimicrobial composition comprising Cornus officinalis extract as an active ingredient.
상기 산수유 추출물은 산수유의 종자 또는 잎 추출물인 것이 바람직하다.It is preferable that the above-mentioned extract is a seed or leaf extract of marine oil.
상기 산수유의 종자 추출물은 산수유 종자의 에탄올 추출물인 것이 바람직하다.The seed extract of corn oil is preferably an ethanol extract of corn oil seed.
상기 산수유 종자의 에탄올 추출물은 상기 에탄올 추출물을 헥센, 에틸아세테이트, 부탄올로 순차 분획하여 얻어지는 에틸아세테이트 분획물, 부탄올 분획물 및 물 잔류물 중 1종 이상인 것이 바람직하다.It is preferable that the ethanol extract of the marine oil seeds is at least one of ethyl acetate fraction, butanol fraction and water residue obtained by successively fractionating the ethanol extract with hexene, ethyl acetate and butanol.
상기 산수유의 종자 추출물은 산수유 종자의 열수 추출물인 것이 바람직하다.Preferably, the seed extract of corn oil is a hydrothermal extract of corn oil seed.
상기 산수유 종자의 열수 추출물은 상기 열수 추출물을 헥센, 에틸아세테이트, 부탄올로 순차 분획하여 얻어지는 헥센 분획물, 에틸아세테이트 분획물, 부탄올 분획물 및 물 잔류물 중 1종 이상인 것이 바람직하다.Preferably, the hot-water extract of the marine oil seeds is at least one of hexane fraction, ethyl acetate fraction, butanol fraction and water residue obtained by successively fractionating the hot-water extract with hexene, ethyl acetate and butanol.
상기 산수유의 잎 추출물은 산수유 잎의 에탄올 추출물인 것이 바람직하다.The leaf extract of corn oil is preferably an ethanol extract of corn oil.
상기 산수유 잎의 에탄올 추출물은 상기 에탄올 추출물을 헥센, 에틸아세테이트, 부탄올로 순차 분획하여 얻어지는 헥센 분획물, 에틸아세테이트 분획물, 부탄올 분획물 및 물 잔류물 중 1종 이상인 것이 바람직하다.It is preferable that the ethanol extract of the acidophilus leaves is at least one of hexane fraction, ethyl acetate fraction, butanol fraction and water residue obtained by successively fractionating the ethanol extract with hexene, ethyl acetate and butanol.
상기 산수유의 잎 추출물은 산수유 잎의 열수 추출물을 헥센, 에틸아세테이트, 부탄올로 순차 분획하여 얻어지는 헥센 분획물, 에틸아세테이트 분획물 및 부탄올 분획물 중 1종 이상인 것이 바람직하다.It is preferable that the leaf extract of the acidified milk is at least one of a hexane fraction, an ethyl acetate fraction and a butanol fraction obtained by successively fractionating a hot-water extract of a corn oil leaf with hexene, ethyl acetate and butanol.
상기 항균은 항세균 또는 항진균인 것이 바람직하다.It is preferable that the antibacterial agent is an antibacterial agent or an antifungal agent.
상기 항균 조성물은 약학 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품 첨가물, 화장품 첨가물, 동물 사료용 첨가물, 세정제 및 청결제로 이루어지는 군으로부터 선택되는 것이 바람직하다.The antimicrobial composition is preferably selected from the group consisting of a pharmaceutical composition, a health functional food, a cosmetic composition, an animal feed composition, a food additive, a cosmetic additive, an animal feed additive, a detergent and a cleanser.
본 발명의 산수유 추출물 및 분획물은 우수한 항균 활성을 나타내어, 항세균 및/또는 항진균용 약학 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품, 화장품 또는 동물 사료용 첨가물, 각종 세정제 및 각종 청결제 등의 용도로 사용할 수 있는 뛰어난 효과가 있다. 뿐만 아니라, 본 발명의 산수유 추출물 및 분획물은 열 안정성이 우수하고, pH 2의 산성조건 및 혈장 내에서도 활성의 손실이 나타나지 않아, 액상, 크림, 분말, 환, 정 등의 다양한 형태로 손쉽게 가공될 수 있어 제약 산업, 식품 산업, 축산업, 보건 산업 및 화장품 산업상 매우 유용하게 이용될 수 있다.The extract of mushroom oil of the present invention exhibits excellent antimicrobial activity and is useful as an antimicrobial and / or antifungal pharmaceutical composition, a health functional food, a cosmetic composition, an animal feed composition, food, cosmetic or animal feed additives, various detergents, There is an excellent effect that can be used for applications. In addition, the acidic milk extract and fractions of the present invention are excellent in thermal stability and can be easily processed into various forms such as liquid, cream, powder, ring, and tablet without showing loss of activity even in an acidic condition of pH 2 and plasma It can be very useful in pharmaceutical industry, food industry, animal husbandry industry, health industry and cosmetics industry.
이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 산수유 추출물을 함유하는 강력한 항균 활성을 나타내는 조성물에 관한 것이다. 본 발명의 발명자는 산수유 추출물, 특히 산수유 종자 또는 잎으로부터 물, 주정, 에탄올, 메탄올 등의 다양한 용매로 추출한 후, 헥센, 에틸아세테이트, 부탄올로 순차적 유기용매 분획물과 물 잔류물을 조제하고, 이들의 강력한 항균 활성을 확인하였다. The present invention relates to a composition exhibiting a strong antimicrobial activity containing a corn oil extract. The inventors of the present invention have found out that the extract of corn oil, especially the marine oil seeds or leaves, is extracted with various solvents such as water, alcohol, ethanol and methanol, and then the organic solvent fraction and the water residue are sequentially prepared with hexene, ethyl acetate and butanol, A strong antibacterial activity was confirmed.
특히, 산수유 종자의 열수 및 에탄올 추출물 및 이들의 분획물들은 그람양성세균, 그람음성세균 및 진균에 대해 광범위한 항균력을 나타내었고, 산수유 잎의 에탄올 추출물 및 이의 분획물들과 산수유 잎의 열수 추출물의 분획물들은 그람양성세균 및 그람음성세균에 대해 광범위한 항균력을 나타내어, 광범위 항균제 등으로 개발될 수 있음을 확인하여 본 발명을 완성하였다.Particularly, hydrothermal and ethanol extracts and their fractions of corn oil seeds showed broad antibacterial activity against Gram positive bacteria, Gram negative bacteria and fungi, and the ethanol extracts and fractions thereof from the leaves of corn oil and the fractions of hydrothermal extract Positive bacterium and gram-negative bacterium, and can be developed as a broad-spectrum antimicrobial agent. Thus, the present invention has been completed.
따라서, 본 발명은 산수유 추출물을 유효성분으로 함유하는 항균 조성물을 제공한다. 상기 조성물은 약학적 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품, 화장품 또는 동물 사료용 첨가물, 세정제 및 각종 청결제의 용도로 적용될 수 있다.Accordingly, the present invention provides an antimicrobial composition comprising an extract of corn oil as an active ingredient. The composition may be applied to a pharmaceutical composition, a health functional food, a cosmetic composition, an animal feed composition, a food, a cosmetic or an animal feed additive, a detergent, and various cleaning agents.
바람직한 구체예로서, 본 발명은 산수유 종자 또는 잎으로부터 활성물질의 용매 추출단계; 산수유 종자 또는 잎 추출물의 순차적 유기용매 분획을 통한 활성성분의 정제단계; 상기 물질의 인간 적혈구 용혈활성 평가단계로 구성된다.In a preferred embodiment, the present invention relates to a method for producing a fermented soybean oil comprising the steps of: Purifying the active ingredient through sequential organic solvent fractions of marine oil seed or leaf extract; And a step of evaluating the hemolysin activity of the substance in the human erythrocyte.
본 발명의 조성물에 포함되는 "산수유 종자 추출물"은 산수유의 종자를 추출하여 얻은 것을 의미하고, 산수유의 종자는 전체 성숙단계의 종자를 포함하고, 성숙한 산수유의 열매로부터 과육을 물리적으로 제거한 후 수득할 수 있다. 수득된 산수유 종자는 그대로 사용하거나, 분쇄된 분말을 사용할 수 있으며, 바람직하게는 산수유 종자를 100메쉬 이하로 분쇄하여 얻은 분말을 사용하는 것이다. 이 밖에도 과육이 제거된 산수유 종자는 추출 과정 전에 열처리를 할 수도 있다."Corn oil seed extract" contained in the composition of the present invention refers to a seed obtained by extracting seeds of corn oil, and seeds of corn oil include seeds of the entire maturity stage and are obtained after physically removing pulp from the fruit of mature corn oil . The obtained crude oil seeds may be used as is or pulverized powder may be used. Preferably, the powder obtained by pulverizing 100% or less of the vegetable oil seeds is used. In addition, corn oil seeds from which flesh is removed may be heat treated before extraction.
본 발명의 항균 활성물질을 함유하는 산수유 종자는 국내 식품공전상 식품원재료로 등록되어 있지 않으며, 적혈구 응집인자인 렉틴을 함유하고 있어, 민간에서는 독성이 있다고 알려져 있으나 정확한 근거는 없다. 현재 산수유 종자는 별도의 용도가 없어 거의 폐기되고 있어, 산수유 종자로부터 매우 경제적으로 항균성 조성물을 제조할 수 있다.The seed oil containing the antimicrobial active substance of the present invention is not registered as a raw material for food in the domestic foodstuffs industry and contains lectin as a red blood cell coagulation factor and is known to be toxic to the public. At present, corn oil seeds are almost discarded because they have no special purpose, and antimicrobial compositions can be produced economically from corn oil seeds.
또한, 본 발명의 조성물에 포함되는 "산수유 잎 추출물"은 산수유의 성숙된 잎을 추출하여 얻은 것을 의미하고, 산수유의 잎은 전체 성숙단계의 잎을 포함하고, 성숙한 산수유 열매를 수확기 전후에 회수하는 것이 바람직하며, 산수유 수확에도 영향을 미치지 않는다. 바람직한 구체예로서, 상기 산수유 잎은 채취한 후 수세하여 이물질을 제거한 후, 음건하여 그대로 사용하거나, 분쇄하여 얻은 잎 분말을 사용할 수 있다. 분쇄된 분말을 사용하는 경우에는 100메쉬 이하로 분쇄하여 사용하는 것이 바람직하다. 추가적으로 음건된 산수유 잎은 덕음 과정 등과 같은 열처리를 수행할 수도 있다.In addition, the "acidophylla leaf extract" contained in the composition of the present invention means that the matured leaf of the matured oil is extracted, the leaves of the matured oil contain the leaves of the entire mature stage, and the mature matured fruit oil is recovered before and after the harvest , And does not affect the harvesting of corn oil. As a preferred specific example, the leaves of the above-mentioned leaves may be collected by washing with water, removing the foreign substances, shredding them, or grinding them. When pulverized powder is used, it is preferable to use pulverized powder to 100 mesh or less. In addition, shrubs of safflower leaves may be subjected to a heat treatment such as a fruiting process.
본 발명의 항균 활성물질을 함유하는 산수유 잎은 국내 식품공전상 식품원재료로 등록되어 있지 않으나, 민간에서는 끊인 물에 우려 차로 음용한 예가 있다. 현재 산수유 잎은 별도의 용도가 없어 거의 폐기되고 있어, 산수유 잎으로부터 매우 경제적으로 항균용 조성물을 제조할 수 있다.The leaves of corn oil containing the antimicrobial active substance of the present invention are not registered as raw materials for food in the domestic food industry, but there is an example in the private sector where drinking water is concerned about the endless water. At present, the leaves of corn oil are almost not used because they are not used separately, and the antimicrobial composition can be produced economically from the corn oil leaves.
본 발명에서 "산수유 종자 추출물" 또는 "산수유 잎 추출물"은 다양한 추출용매를 이용하여 제조할 수 있다. 예를 들어, 물(냉수, 열수), 주정, 탄소수 1~4의 무수 또는 함수 저급 알코올(메탄올, 에탄올, 주정, 프로판올, 부탄올 등), 상기 저급알코올과 물과의 혼합용매 등을 이용하며 제조할 수 있다. 바람직하게는 에탄올 또는 주정을 사용하여 추출하는 경우 최대의 활성물질의 수율을 나타내며, 경제적 추출의 경우에는 열수를 사용하는 것이 바람직하며. 본 발명의 산수유 종자 또는 잎 추출물은 감압증류 및 동결건조, 또는 분무건조 등과 같은 통상적인 분말화 과정을 거쳐 분말로 제조될 수 있다. 이들은 100℃의 열처리와 pH 2의 인체 위 내의 pH에서도 활성을 유지한다.In the present invention, "corn oil seed extract" or "corn oil leaf extract" may be prepared using various extraction solvents. For example, water (cold water, hot water), alcohol, water, or a lower alcohol having 1 to 4 carbon atoms (methanol, ethanol, alcohol, propanol, butanol, etc.) can do. Preferably, the extraction is carried out using ethanol or alcohol, and the yield of the active material is the maximum. In the case of economic extraction, it is preferable to use hot water. The corn oil seed or leaf extract of the present invention can be made into powder by a conventional powdering process such as vacuum distillation and freeze drying or spray drying. They maintain their activity even at 100 ° C heat treatment and pH 2 in human body.
본 발명의 산수유 종자 또는 잎의 열수 추출물 및 에탄올 추출물과 이들의 순차적 분획물은 강력한 항균 활성을 나타내어, 병원성 세균 및 진균의 감염의 예방 또는 치료와 관련되는 약학 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품, 화장품, 동물 사료용 첨가물 및 각종 청결제의 소재로 사용될 수 있다.The hot-water extract and the ethanol extract and the sequential fraction thereof of the seed oil or seed of the present invention exhibit a strong antimicrobial activity and are useful as a pharmaceutical composition, a health functional food, a cosmetic composition, an animal feed or the like for preventing or treating infection of pathogenic bacteria and fungi Compositions, foods, cosmetics, animal feed additives, and various cleaning agents.
바람직한 구체예로서, 본 발명의 항균 조성물은 약학적 조성물의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as a pharmaceutical composition.
상기 약학적 조성물은 각각의 사용 목적에 맞게 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁제, 에멀젼, 시럽, 에어로졸 등의 경구 제형, 멸균 주사용액의 주사제 등 다양한 형태로 제형화하여 사용할 수 있으며, 경구 투여하거나 정맥 내, 복강 내, 피하, 직장, 국소 투여 등을 포함한 다양한 경로를 통해 투여될 수 있다. 이러한 약학적 조성물에는 추가적으로 담체, 부형제 또는 희석제 등이 더 포함될 수 있으며, 포함될 수 있는 적합한 담체, 부형제 또는 희석제의 예로는 락토오스, 덱스트로오스, 수크로오스, 솔비톨, 만니톨, 자일리톨, 에리쓰리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로스, 메틸 셀룰로스, 비정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸하이드록시벤조에이트, 프로필하이드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유 등을 들 수 있다. 또한, 본 발명의 약학적 조성물은 충전제, 항응집제, 윤활제, 습윤제, 향료, 유화제, 방부제 등을 추가로 더 포함할 수도 있다. The pharmaceutical composition may be formulated into various forms such as powders, granules, tablets, capsules, oral formulations such as suspensions, emulsions, syrups and aerosols, injections of sterilized injection solutions, etc. And can be administered via various routes including oral administration or intravenous, intraperitoneal, subcutaneous, rectal, topical administration, and the like. Such pharmaceutical compositions may further comprise carriers, excipients or diluents, and examples of suitable carriers, excipients or diluents that may be included include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, But are not limited to, starch, acacia gum, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methylcellulose, amorphous cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, And the like. In addition, the pharmaceutical composition of the present invention may further include a filler, an anti-coagulant, a lubricant, a wetting agent, a flavoring agent, an emulsifying agent, an antiseptic, and the like.
본 발명의 약학적 조성물은 약제학적으로 유효한 양으로 투여한다. 본 발명에서, "약제학적으로 유효한 양"은 의학적 치료에 적용 가능한 합리적인 수혜/위험 비율로 질환을 치료하기에 충분한 양을 의미하며, 유효 용량 수준은 환자의 질환의 종류, 중증도, 약물의 활성, 약물에 대한 민감도, 투여 시간, 투여 경로 및 배출 비율, 치료 기간, 동시 사용되는 약물을 포함한 요소 및 기타 의학 분야에 잘 알려진 요소에 따라 결정될 수 있다. 본 발명의 약학적 조성물은 개별 치료제로 투여하거나 다른 치료제와 병용하여 투여될 수 있고, 종래의 치료제와 순차적으로 또는 동시에 투여될 수 있으며, 단일 또는 다중 투여될 수 있다. 상기한 요소들을 모두 고려하여 부작용 없이 최소한의 양으로 최대 효과를 얻을 수 있는 양을 투여하는 것이 중요하며, 이는 당업자에 의해 용이하게 결정될 수 있다. The pharmaceutical composition of the present invention is administered in a pharmaceutically effective amount. In the present invention, "pharmaceutically effective amount" means an amount sufficient to treat a disease at a reasonable benefit / risk ratio applicable to medical treatment, and the effective dose level will depend on the type of disease, severity, The sensitivity to the drug, the time of administration, the route of administration and the rate of release, the duration of the treatment, factors including co-administered drugs, and other factors well known in the medical arts. The pharmaceutical composition of the present invention may be administered as an individual therapeutic agent or in combination with other therapeutic agents, and may be administered sequentially or simultaneously with conventional therapeutic agents, and may be administered singly or multiply. It is important to take into account all of the above factors and to administer the amount in which the maximum effect can be obtained in a minimal amount without side effects, which can be easily determined by those skilled in the art.
본 발명의 약학적 조성물에서 항균 활성을 갖는 성분의 유효량은 환자의 나이, 성별, 체중에 따라 달라질 수 있으며, 일반적으로는 체중 당 1 내지 5,000mg, 바람직하게는 100 내지 3,000mg을 매일 또는 격일 투여하거나 1일 1 내지 3회로 나누어 투여할 수 있다. 그러나, 투여 경로, 질병의 중증도, 성별, 체중, 연령 등에 따라서 증감될 수 있으므로 상기 투여량이 어떠한 방법으로도 본 발명의 범위를 한정하는 것은 아니다. 본 발명의 약학적 조성물은 다양한 경로를 통하여 대상에 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁내 경막 또는 뇌혈관 내(intracerebroventricular) 주사에 의해 투여될 수 있다. 본 발명에서 "투여"는 임의의 적절한 방법으로 환자에게 소정의 물질을 제공하는 것을 의미하며, 본 발명의 약학적 조성물의 투여 경로는 목적 조직에 도달할 수 있는 한 일반적인 모든 경로를 통하여 경구 또는 비경구 투여될 수 있다. 또한, 본 발명의 조성물은 유효성분을 표적 세포로 전달할 수 있는 임의의 장치를 이용해 투여될 수도 있다. 본 발명에서 "대상"은, 특별히 한정되는 것은 아니지만, 예를 들어, 인간, 원숭이, 소, 말, 양, 돼지, 닭, 칠면조, 메추라기, 고양이, 개, 마우스, 쥐, 토끼 또는 기니아 피그를 포함하고, 바람직하게는 포유류, 보다 바람직하게는 인간을 의미한다. The effective amount of the component having antimicrobial activity in the pharmaceutical composition of the present invention may vary depending on the age, sex and body weight of the patient, and is generally from 1 to 5,000 mg, preferably from 100 to 3,000 mg per body weight, Or one to three times a day. However, the dosage may not be limited in any way because it may be increased or decreased depending on route of administration, severity of disease, sex, weight, age, and the like. The pharmaceutical composition of the present invention can be administered to a subject through various routes. All modes of administration may be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intra-uterine or intracerebroventricular injections. In the present invention, "administration" means providing a predetermined substance to a patient by any suitable method, and the administration route of the pharmaceutical composition of the present invention is either oral or non-oral May be administered orally. The composition of the present invention may also be administered using any device capable of delivering an effective ingredient to a target cell. In the present invention, the term "object" includes, but is not limited to, human, monkey, cow, horse, sheep, pig, chicken, turkey, quail, cat, dog, mouse, rat, rabbit or guinea pig , Preferably a mammal, more preferably a human.
바람직한 구체예로서, 본 발명의 항균 조성물은 건강 기능 식품의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as a health functional food.
본 발명의 건강 기능 식품은 병원성 미생물의 감염 우려가 높은 대상으로부터 감염의 가능성을 낮추어 줄 수 있는 효과적인 식품 및 음료 등에 다양하게 이용될 수 있다. 본 발명의 항균 활성이 우수한 유효성분을 포함하는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강보조 식품류 등이 있고, 분말, 과립, 정제, 캡슐 또는 음료인 형태로 사용할 수 있다. 본 발명의 활성 성분은 일반적으로 전체 식품 중량의 0.01 내지 15중량%로 가할 수 있으며, 건강음료 조성물은 100 ml를 기준으로 0.02 내지 10g, 바람직하게는 0.3 내지 1g의 비율로 가할 수 있다. 본 발명의 건강 기능 식품은 지시된 비율로 필수 성분으로서 상기 화합물을 함유하는 것 외에 식품학적으로 허용 가능한 식품보조 첨가제, 예컨대, 천연 탄수화물 및 다양한 향미제 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물의 예로는 포도당, 과당 등의 단당류, 말토오스, 수크로오스 등의 이당류 및 덱스트린, 시클로덱스트린 등의 다당류와 같은 통상적인 당 및 자일리톨, 소르비톨, 에리쓰리톨 등의 당알코올이 있다. 상기 향미제로는 타우마틴, 레바우디오시드 A, 글리시르히진, 사카린, 아스파르탐 등을 사용할 수 있다. 상기 향미제의 비율은 본 발명의 건강 기능 식품 100ml당 일반적으로 약 1 내지 20g, 바람직하게는 약 5 내지 12g을 사용한다. 상기 외에 본 발명의 건강 기능 식품은 여러 가지 영양제, 비타민, 광물, 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 건강 기능 식품은 천연 과일 주스 및 과일 주스 음료 및 야채 음료 등의 제조를 위한 과육을 함유할 수도 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 본 발명의 상기 활성 분획물 100 중량부 당 0.01 내지 약 20중량부의 범위에서 선택되는 것이 일반적이다. The health functional food of the present invention can be used variously for effective foods and beverages which can lower the possibility of infection from a subject having a high risk of infection by a pathogenic microorganism. Examples of food containing the active ingredient having excellent antimicrobial activity of the present invention include various foods, beverages, gums, tea, vitamin complexes, health supplement foods and the like, and may be in the form of powders, granules, tablets, capsules or beverages . The active ingredient of the present invention may generally be added in an amount of 0.01 to 15% by weight of the total food, and the health beverage composition may be added in a proportion of 0.02 to 10 g, preferably 0.3 to 1 g, based on 100 ml. The health functional food of the present invention may contain, as an additional ingredient, a food-acceptable food-aid additive such as natural carbohydrates and various flavors, in addition to containing the above-mentioned compound as an essential ingredient in the indicated ratio. Examples of the natural carbohydrate include sugar sugars such as glucose, monosaccharides such as fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. Examples of the flavor agent include tau martin, rebaudioside A, glycyrrhizin, saccharin, and aspartame. The proportion of the above-mentioned flavoring agent is generally about 1 to 20 g, preferably about 5 to 12 g per 100 ml of the health functional food of the present invention. In addition to the above, the health functional food of the present invention may contain various kinds of nutrients, vitamins, minerals, flavors such as synthetic flavors and natural flavors, colorants and heavy stabilizers, pectic acid and its salts, alginic acid and its salts, Thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like. In addition, the health functional food of the present invention may contain flesh for producing natural fruit juice, fruit juice drink, vegetable drink and the like. These components may be used independently or in combination. The ratio of such additives is generally selected in the range of 0.01 to about 20 parts by weight per 100 parts by weight of the active fraction of the present invention.
바람직한 구체예로서, 본 발명의 항균 조성물은 화장료 조성물의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as a cosmetic composition.
본 발명의 화장료 조성물은 본 발명의 항균 활성이 우수한 성분을 예를 들어, 에센스, 영양크림, 바디로션, 린스, 샴푸, 바디클렌저, 로션, 스킨, 마스크팩 등의 형태로 제조될 수 있으며, 여기에 한정되는 것은 아니다. 상기 형태로의 제조는 당업자에게 알려진 다양한 제조 공정에 따라 용이하게 수행될 수 있을 것이다.The cosmetic composition of the present invention can be manufactured in the form of an ingredient having excellent antimicrobial activity of the present invention in the form of an essence, a nutritional cream, a body lotion, a rinse, a shampoo, a body cleanser, a lotion, a skin, . The preparation in this form may be easily carried out according to various production processes known to those skilled in the art.
바람직한 구체예로서, 본 발명의 항균 조성물은 동물 사료 조성물의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as an animal feed composition.
상기 동물은 식물에 대응하는 생물군으로 주로 유기물을 영양분으로 섭취하며, 소화나 배성 및 호흡기관이 분화되어 있는 것을 말하고, 구체적으로는 극피동물, 갑각류, 연체동물, 어류, 양서류, 파충류, 조류, 포유류일 수 있으며, 바람직하게는 성게류 또는 해삼류와 같은 극피동물, 게, 새우, 대하 등의 갑각류를 포함하는 절지동물, 두족류, 복족류 또는 이매패류 등의 연체동물, 참돔, 도미, 대구, 가자미, 넙치 등의 어류, 꿩 또는 닭 등의 가금류를 포함하는 조류 또는 돼지, 소, 염소 등의 포유류일 수 있다.The animal is an organism corresponding to a plant and mainly consumes organic matter as nutrients and refers to the digestion, reproduction and differentiation of the respiratory organs. Specifically, the animal is an animal such as an echinoderm, crustacean, mollusk, fish, amphibian, reptile, Mammals and preferably molluscs such as echinoderms such as echinoderms or sea cucumbers, arthropods including crustaceans such as crabs, shrimps and prawns, cephalopods, gastropods or bivalves such as sea buckets, sea breams, codfish, , Flounder or the like, poultry such as pheasant or chicken, or a mammal such as pig, cattle, or goat.
상기 동물 사료용 조성물은 본 발명의 항균 성분을 포함하는 항균 조성물에 곡물, 식물성 단백질 사료, 동물성 단백질 사료, 당분 또는 유제품을 추가로 포함할 수 있다. 상기 곡물은 구체적으로는 분쇄 또는 파쇄된 밀, 귀리, 보리, 옥수수 및 쌀일 수 있고, 상기 식물성 단백질 사료는 구체적으로는 평지, 콩 및 해바라기를 주성분으로 하는 것일 수 있으며, 상기 동물성 단백질 사료는 구체적으로는 혈분, 육분, 골분 및 생선분일 수 있고, 상기 당분 또는 유제품은 구체적으로는 각종 분유 및 유장 분말로 이루어지는 건조성분일 수 있다.The composition for animal feed can further comprise cereals, vegetable protein feeds, animal protein feeds, sugar or dairy products in the antimicrobial composition comprising the antimicrobial component of the present invention. The cereal may be specifically wheat, crushed or crushed wheat, oats, barley, corn and rice, and the vegetable protein feed may be one mainly composed of rapeseed, bean and sunflower, and the animal protein feed is specifically May be blood, meat, bone meal, and fish meal, and the sugar or dairy product may specifically be a dry ingredient consisting of various powdered milk and whey powders.
상기 동물 사료용 조성물은 추가로 영양 보충제, 소화 및 흡수 향상제, 성창 촉진제 또는 질병 예방제와 같은 성분을 함께 사용할 수 있다.The animal feed composition may further contain ingredients such as nutritional supplements, digestion and absorption enhancers, sex-promoting agents or disease prevention agents.
본 발명의 동물 사료용 조성물에 포함되는 항균 조성물은 사료의 사용목적 및 사용조건에 따라 달라질 수 있으며, 일 예로 최종 생산된 사료 1kg을 기준으로 상기 항균성 조성물이 0.1g 내지 100g 포함될 수 있다.The antimicrobial composition contained in the composition for animal feed of the present invention may be varied depending on the intended use and the conditions of use of the feed. For example, 0.1 to 100 g of the antimicrobial composition may be contained based on 1 kg of the final feed.
또한, 상기 사료 조성물은 성분들의 분쇄 정도에 따라 경점성의 조립 또는 과립 물질로 제조될 수 있으며, 상기 조성물은 메쉬로 공급되거나 추가 가공 및 포장을 위해 원하는 분리된 형상으로 형성시킬 수 있으며, 저장을 위해 펠렛화, 팽창화 또는 압출 공정을 거칠 수 있으며, 저장의 용이성을 위해 바람직하게는 과잉의 물을 건조 제거될 수 있다.In addition, the feed composition can be made into a light-viscous granulated or granulated material depending on the degree of comminution of the components, which can be fed into a mesh or formed into a desired discrete shape for further processing and packaging, Pelletizing, expanding or extruding processes, and preferably excess water can be dried off for ease of storage.
바람직한 구체예로서, 본 발명의 항균 조성물은 식품, 화장품 또는 동물 사료용 첨가제의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as an additive for foods, cosmetics or animal feeds.
상기 첨가제는 사용되는 식품, 화장품 또는 동물 사료에 보존성을 부여하기 위하여 첨가되는 것으로서, 상기 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로 식품, 화장품 또는 동물용 사료에 안전하게 적용할 수 있다.The additive is added to impart preservability to food, cosmetics or animal feed used. Since the antimicrobial composition is a natural ingredient and is not harmful to human body, it can be safely applied to foods, cosmetics or animal feeds.
상기 첨가제는 그 사용 목적 및 용도에 따라 적의 선택된 추가적인 여타의 첨가물을 추가로 더 포함할 수 있으며, 통상적으로 사용되는 첨가물 등 다른 유효성분이나 색소, 계면활성제, 방부제 등의 첨가물과 혼합하여 사용할 수 있다. 상기 첨가제는 그 사용 목적 및 용도에 따라 분말화, 과립화, 정제화 또는 액상화하여 제조될 수 있으며, 제품화를 위하여 포장을 위해 통상의 방법을 사용할 수 있다.The additive may further include other optional additives selected depending on the purpose and use of the additive, and may be mixed with other active ingredients, such as commonly used additives, or additives such as pigments, surfactants, and preservatives . The additive may be prepared by pulverizing, granulating, tableting or liquefying according to the purpose and use of the additive. For commercialization, a conventional method may be used for packaging.
또한, 상기 첨가제 중 항균 조성물의 사용량은 사용목적과 적용형태, 적용부위, 적용대상물품 등에 따라 적절히 사용될 수 있으며, 예를 들면 전체 조성물 기준으로 0.01 중량부 내지 50 중량부를 포함할 수 있으나, 상기 항균 조성물의 함량은 이에 한정되는 것은 아니다. 본원 발명의 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로, 그 제품의 특성상 적용목적을 달성할 수 있는 경우라면 다양한 양으로 사용가능하다.The amount of the antimicrobial composition to be used may be appropriately used depending on the purpose of use, the application form, the application site, the object to be applied, and the like. For example, the antimicrobial composition may contain 0.01 to 50 parts by weight, The content of the composition is not limited thereto. Since the antimicrobial composition of the present invention is a natural component and is not harmful to human body, it can be used in various amounts as long as the application purpose can be achieved due to the characteristics of the product.
바람직한 구체예로서, 본 발명은 항균 조성물은 세정제의 용도로서 적용될 수 있다.In a preferred embodiment, the present invention can be applied as an application of a cleaning agent.
상기 세정제는 바람직하게는 의류용 세제, 식기 세척제, 식품 세정제, 가전제품 세척제일 수 있다. 상기 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로, 더욱 바람직하게는 주방용품 또는 식품세척 등을 포함하는 각종 생활용품의 세척이나 항균성 부여를 목적으로 사용할 수 있다.The detergent may preferably be a detergent for clothes, a dishwasher, a food cleaner, or a household appliance cleaner. The antimicrobial composition is a natural ingredient and is not harmful to human body. Therefore, it is more preferably used for the purpose of washing or antibacterial property of various daily necessities including kitchen utensil or food washing.
상기 세정제는 그 사용 목적 및 용도에 따라 적의 선택된 첨가물을 추가로 포함할 수 있으며, 통상적으로 사용되는 세정제 등 다른 유효성분이나 색소, 계면활성제, 방부제 등의 첨가제와 혼합하여 사용할 수 있다. 상기 세정제는 그 사용 목적 및 용도에 따라 분말화, 과립화, 정제화 또는 액상화하여 제조될 수 있으며, 제품화를 위하여 포장을 위해 통상의 방법을 사용할 수 있다.The detergent may further contain an adversely selected additive depending on the purpose and use of the detergent. The detergent may be mixed with other active ingredients, such as detergents, and additives such as pigments, surfactants and preservatives. The detergent may be prepared by pulverizing, granulating, tableting or liquefying according to the purpose and use of the detergent, and a conventional method may be used for packaging for commercialization.
또한, 상기 세정제 중 항균성 조성물의 사용량은 사용목적과 적용형태, 적용부위, 적용대상물품 등에 따라 적절히 사용될 수 있으며, 예를 들면 전체 조성물 기준으로 0.01 중량부 내지 50 중량부를 포함할 수 있으나, 상기 항균성 조성물의 함량은 이에 한정되는 것은 아니다. 본원 발명의 항균성 조성물은 천연성분으로 인체에 유해하지 아니하므로, 그 제품의 특성상 적용목적을 달성할 수 있는 경우라면 다양한 양으로 사용가능하다.The amount of the antimicrobial composition to be used in the cleaning agent may be appropriately used depending on the purpose of use, the application form, the application site, the article to be applied, and the like. For example, the antimicrobial composition may contain 0.01 to 50 parts by weight, The content of the composition is not limited thereto. Since the antimicrobial composition of the present invention is a natural ingredient and is not harmful to human body, it can be used in various amounts as long as its application purpose can be achieved.
바람직한 구체예로서, 본 발명은 항균 조성물은 청결제의 용도로서 적용될 수 있다.As a preferred embodiment, the present invention can be applied as an antibacterial composition for use as a cleansing agent.
상기 청결제는 일상 생활에서 흔히 감염되기 쉬운 병원성 미생물의 체내 감염을 예방 차원에서 수행하기 위하여 간단한 방법으로 손, 구강 또는 여성용 청결제 등의 용도로 사용될 수 있다. 상기 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로 손, 구강, 여성용 청결제로 사용하는 경우에도 안전하게 적용할 수 있다.The cleaner can be used for hand, oral cavity or ladies' cleanser in a simple manner to prevent infection of a pathogenic microorganism which is easily infected in daily life. Since the antimicrobial composition is a natural ingredient and is not harmful to the human body, it can be safely applied even when it is used as a hand, mouth, and female cleanser.
상기 청결제는 그 사용 목적 및 용도에 따라 적의 선택된 추가적인 여타의 첨가물을 추가로 더 포함할 수 있으며, 통상적으로 사용되는 첨가물 등 다른 유효성분이나 색소, 계면활성제, 방부제 등의 첨가물과 혼합하여 사용할 수 있다. 상기 청결제는 그 사용 목적 및 용도에 따라 분말화, 과립화, 정제화 또는 액상화하여 제조될 수 있으나, 액상형의 경우 편리한 사용이 가능할 것이다.The cleansing agent may further include other additives optionally selected depending on the purpose and use of the cleansing agent. The cleansing agent may be mixed with other active ingredients, such as commonly used additives, and additives such as coloring matters, surfactants and preservatives . The cleansing agent may be prepared by pulverization, granulation, tableting or liquefying according to the purpose and use of the cleansing agent.
또한, 상기 청결제 중 항균 조성물의 사용량은 사용목적과 적용형태, 적용부위 등에 따라 적절히 사용될 수 있으며, 예를 들면 전체 조성물 기준으로 0.01 중량부 내지 50 중량부를 포함할 수 있으나, 상기 항균 조성물의 함량은 이에 한정되는 것은 아니다. 본원 발명의 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로, 그 제품의 특성상 적용목적을 달성할 수 있는 경우라면 다양한 양으로 사용가능하다.In addition, the amount of the antimicrobial composition to be used in the cleaner may be suitably used according to the purpose of use, application form, application site, and the like. For example, the amount of the antimicrobial composition may be 0.01 to 50 parts by weight, But is not limited thereto. Since the antimicrobial composition of the present invention is a natural component and is not harmful to human body, it can be used in various amounts as long as the application purpose can be achieved due to the characteristics of the product.
이하에서는 실시예를 통하여 본 발명을 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail with reference to Examples.
<< 실시예Example >>
실시예Example 1 One
1. 산수유 종자의 다양한 용매 추출1. Various solvent extraction of corn oil seeds
경북 의성에서 2011년 12월 수확한 산수유로부터 씨를 분리한 후, 흐르는 물에 수세하여 과육을 제거하고, 이를 7일간 음건한 후 100메쉬로 분쇄한 후 추출에 사용하였다. 추출용매로는 헥센, 에탄올(95%), 메탄올(70%), 열수(70℃ 및 100℃)를 사용하였으며, 분쇄 종자 무게 대비 10배의 유기용매를 가한 후 상온에서 24시간씩 3회 추출하거나, 10배의 열수를 가한 후 70℃ 또는 100℃에서 30분간 추출하였다. 추출물은 감압 농축하여 분말로 제조하였으며, 사용 전까지 저온 밀봉 보관하였다. 조제된 산수유 종자 추출물의 총 플라보노이드(total flavonoid) 및 총 폴리페놀(total polyphenol) 함량, 총당 및 환원당 함량을 측정하였으며, 총 플라보노이드 함량의 표준품으로는 rutin, 총 폴리페놀 함량의 표준품으로 tannic acid을 사용하였다. 환원당은 DNS법으로, 총당은 phenol-sulfuric acid법을 이용하여 정량하였다. 각각의 추출물의 추출효율 및 성분 분석결과는 표 1에 나타내었으며, 가장 높은 수율은 에탄올 추출에서 나타났으나, 열수 추출의 경우에도 양호한 결과를 나타내었다. 성분 분석 결과 가장 큰 차이는 폴리페놀 함량에서 나타났으며, 에탄올 및 메탄올 추출물은 열수 추출물보다 높은 함량의 폴리페놀 함량을 나타내었다. 그러나, 플라보노이드 함량은 헥센 추출의 경우를 제외하면 14.31~20.06mg/g의 분포를 나타내었다. 일반적으로 천연물의 항균활성이 폴리페놀 및 플라보노이드 성분에 기인함을 고려할 때, 산수유 종자는 매우 높은 폴리페놀 및 플라보노이드 함량은 강력한 항균 활성과 관련되리라 판단되었다.After separating the seeds from the cornstarch oil harvested in December 2011 in Gyeongbuk province, the pulp was washed with running water to remove the pulp, shredded for 7 days, and crushed into 100 mesh. The extraction solvent was hexane, ethanol (95%), methanol (70%), hot water (70 ℃ and 100 ℃), and 10 times of organic solvent was added to the weight of the crushed seeds. Or 10 times of hot water, and then extracted at 70 ° C or 100 ° C for 30 minutes. The extract was concentrated under reduced pressure to give a powder, which was stored at low temperature until use. Total flavonoid and total polyphenol contents, total sugar and reducing sugar contents of the prepared extracts were measured. As the standard of total flavonoid content, rutin and tannic acid were used as the standard of total polyphenol content. Respectively. Reducing sugar was determined by DNS method and total sugar was quantified by phenol-sulfuric acid method. The extraction efficiency and component analysis results of each extract are shown in Table 1, and the highest yield was obtained in ethanol extraction, but also in hot water extraction. The most significant difference was found in polyphenol contents, and ethanol and methanol extracts showed higher contents of polyphenols than hot water extracts. However, the content of flavonoids was 14.31 ~ 20.06 mg / g except for the extraction with hexene. Considering that the antimicrobial activity of natural products is generally attributed to polyphenols and flavonoids, it was concluded that the high content of polyphenols and flavonoids in corn oil seeds might be associated with strong antimicrobial activity.
가장 높은 추출효율을 나타낸 에탄올 추출물 및 경제적 추출이 가능한 열수(100℃) 추출물을 대상으로 순차적 유기용매 분획을 실시하였으며, 그 결과는 표 2에 나타내었다. The ethanol extracts exhibiting the highest extraction efficiency and the hot water (100 ° C) extracts capable of economical extraction were subjected to sequential organic solvent fractionation, and the results are shown in Table 2.
(%)Fraction
(%)
추출물Ethanol (95%)
extract
(100℃)
추출물Heat number
(100 DEG C)
extract
산수유 종자의 에탄올 추출물은 에틸아세테이트 및 부탄올 분획물이 추출물 대비 70.3%, 헥센 분획물은 0.1% 이었으나, 열수 추출물의 경우 에틸아세테이트 및 부탄올 분획물은 추출물 대비 66.7%로 유사하였으나, 헥센 분획물은 10.9%를 나타내어 많은 차이를 보였다. 상기 추출물의 유기용매 분획 후 물 잔류물의 양은 22.0~28.2%로 유사하였다. 분획물의 폴리페놀 및 플라보노이드 함량은 에탄올 추출물에서 부탄올 분획 > 에틸아세테이트 분획 > 물 잔류물 > 헥센 분획으로 나타났으나, 열수 추출물의 경우 에틸아세테이트 분획 > 부탄올 및 헥센 분획 > 물 잔류물 순으로 나타나 많은 차이를 나타내었다. The ethyl acetate and butanol fractions were similar to the extracts, but the hexane fractions were 10.9%. The ethyl acetate and butanol fractions were 70.3% and 0.1%, respectively. Respectively. The amount of water residue after fractionation of the organic solvent of the extract was 22.0 ~ 28.2%. The contents of polyphenols and flavonoids in the fractions were as follows: butanol fraction> ethyl acetate fraction> water residue> hexane fraction in the ethanol extract, ethyl acetate fraction, butanol and hexane fraction> Respectively.
2. 산수유 종자 추출물 및 2. Corn oil seed extract and 분획물의Fraction 항균 활성 Antimicrobial activity
조제된 산수유 종자 시료들을 이용하여 항균 활성을 평가하였으며, 그람 음성균으로 Escherichia coli KCTC 1682, Proteus vulgaris KCTC 2433, Salmonella typhimurium KCTC 1926을 사용하였고, 그람 양성균으로는 Staphylococcus aureus KCTC 1916, Listeria monocytogenes KACC 10550, Bacillus subtilis KCTC 1924를 사용하였다. 한편, 항진균 활성 평가를 위해서는 Saccharomyces cerevisiae IF0 0233 및 캔디다증 진균감염증 원인균 Candida albicans KCTC 1940을 사용하였다. Escherichia coli KCTC 1682, Proteus vulgaris KCTC 2433 and Salmonella typhimurium KCTC 1926 were used as Gram-negative bacteria. Staphylococcus aureus KCTC 1916, Listeria monocytogenes KACC 10550, Bacillus spp. subtilis KCTC 1924 was used. Saccharomyces cerevisiae IF0 0233 and Candida albicans KCTC 1940, the causative agent of fungus infections, were used for evaluation of antifungal activity.
먼저, 항세균 활성 평가의 경우, Nutrient broth(Difco Co., USA)에 각각의 세균을 접종하여 37℃에서 24시간 동안 배양한 후, 각 균주를 O.D.600 0.1로 조정하여 Nutrient agar(Difco Co., USA) 배지를 포함하는 멸균 petri dish(9015mm, 녹십자, 한국)에 100μl씩 도말하고, 각각의 시료 5μl를 멸균 disc-paper(지름 6.5mm, Whatsman No. 2)에 가하여, 37℃에서 24시간 동안 배양하였으며, 진균의 경우에는 Sabouraud dextrose(Difco Co. USA)를 이용하여 동일한 방법으로 30℃에서 24시간 동안 배양 후, 생육저지환의 크기를 측정하여 항균활성을 평가하였다. 대조구로는 항세균제인 엠피실린(ampicillin)과 항진균제인 마이코나졸(miconazole, Sigma Co., USA)을 각각 1g/disc 농도로 사용하였으며, 생육저지환의 크기는 육안으로 생육이 나타나지 않는 부분의 지름을 mm 단위로 측정하였고, 3회 이상 평가 후 대표 결과로 표 3에 나타내었다.First, the case wherein the bacterial activity evaluation, Nutrient broth (Difco Co., USA) and then inoculated to each of the bacteria were cultured at 37 ℃ for 24 hours, by adjusting the respective strain to OD 600 0.1 Nutrient agar (Difco Co. (Diameter 6.5mm, Whatsman No. 2) was added to each well of a sterilized petri dish (9015 mm, Green Cross, Korea) containing the medium . In the case of fungi, Sabouraud dextrose (Difco Co., USA) was cultured in the same manner at 30 ° C for 24 hours, and the size of the growth inhibition rings was measured to evaluate the antimicrobial activity. As control, ampicillin, an antimicrobial agent, and miconazole (Sigma Co., USA), an antifungal agent, were used at a concentration of 1 g / disc, respectively. The size of the growth inhibition ring was determined by the naked eye mm, and is shown in Table 3 as representative results after three or more evaluations.
(1 g/disc) Antibiotic
(1 g / disc)
(500 μg/disc)Corn oil seed ethanol extract
(500 μg / disc)
(500 μg/disc)Corn oil seed hot water extract
(500 μg / disc)
실린MP
Syllable
아세테이트 분획물 ethyl
Acetate fraction
잔류물water
Residue
아세테이트 분획물 ethyl
Acetate fraction
잔류물water
Residue
세균Gram negative
Germ
세균Gram positive
Germ
ECEC : : EscherichiaEscherichia colicoli ,,
PVPV : : ProteusProteus vulgarisvulgaris , ,
STST : : SalmonellaSalmonella typhimuriumtyphimurium , ,
SASA : : StaphylococcusStaphylococcus aureusaureus , ,
LMLM : : ListeriaListeria monocytogenesmonocytogenes , ,
BSBS : : BacillusBacillus subtilissubtilis , ,
SCSC : : SaccharomycesSaccharomyces cerevisiaecerevisiae , ,
CACA : : CandidaCandida albicansalbicans . .
-: 생육저해 없음. -: No growth inhibition.
상기 표 3에 나타낸 바와 같이, 항세균 활성대조구로 사용된 엠피실린(1g/disc)의 경우 10.0~36.0mm의 생육억제환을 나타내어 강력한 항세균 활성을 확인하였으며, 항진균제인 마이코나졸(1g/disc)의 경우 C. albicans에 대해 28mm의 생육억제환을 나타내었다. 산수유 종자 추출물의 경우, 에탄올 추출물(500g/disc) 및 이의 분획물들인 에틸아세테이트 분획물, 부탄올 분획물 및 물 잔류물과 산수유 종자의 물 추출물 및 모든 분획물에서는 사용균주 모두에 대해 강력한 항세균 및 항균활성이 확인되어 산수유 종자가 다양한 항균 활성물질을 포함하고 있음을 알 수 있었다. 특이하게 에탄올 추출물의 헥센 분획에서는 항균 활성이 전혀 나타나지 않은 바, 향후 산수유 종자의 헥센 처리 이후 추출물 제조, 또는 에탄올 추출물 조제 이후 헥센 용해성 물질을 제거한 활성물질을 사용하는 경우 경제적인 광범위 항생제로 사용가능하리라 판단된다. 상기의 결과는 산수유 종자 추출물 및 활성 분획물을 식중독 유발균, 병원성 균들의 제어에 효과적으로 이용 가능함을 제시하고 있다. As shown in the above Table 3, the ampicillin (1 g / disc) used as an anti-bacterial activity control exhibited a strong inhibitory activity of 10.0-36.0 mm, indicating that the antifungal agent myconezol (1 g / disc ) Showed growth inhibition ring of 28mm against C. albicans . In the case of the extract of corn oil, the ethanol extract (500 g / disc) and its fractions ethyl acetate fraction, butanol fraction, water residue and water extract of the marine oil seeds and all fractions were found to have strong antibacterial and antimicrobial activity And it was found that corn oil seeds contain various antimicrobial active substances. Especially, the hexane fraction of the ethanol extract does not exhibit any antibacterial activity. Therefore, when the extract is prepared after the hexene treatment of the crude oil seeds, or when the active substance in which the hexane-soluble substance is removed after the preparation of the ethanol extract is used, it can be used as an economical broad-spectrum antibiotic . The above results suggest that the extract of corn oil seeds and the active fractions can be effectively used to control foodborne pathogens and pathogenic bacteria.
3. 산수유 종자 추출물 및 3. Corn oil seed extract and 분획물의Fraction 인간 적혈구 Human red blood cells 용혈활성Hemolytic activity
산수유 종자 시료들의 적혈구 용혈활성을 평가한 결과는 표 4에 나타내었다. 먼저, 대조구로 사용된 DMSO와 증류수는 용혈활성이 없었으며, triton X-100은 0.1% 농도에서 적혈구를 100% 용혈시킴을 확인하였다. 0.5mg/ml 농도에서, 산수유 종자 시료 중에서는 에탄올 추출물 및 이의 에틸아세테이트 분획물에서만 33% 이상의 용혈활성이 나타나 잠재적인 독성이 있는 것으로 나타났으며. 그 외의 시료는 용혈활성이 나타나지 않았다.Table 4 shows the results of evaluating the erythrocyte hemolytic activity of the seed oil samples. First, DMSO and distilled water used as a control had no hemolytic activity, and triton X-100 was found to hemolyze red blood cells at a concentration of 0.1%. At the concentration of 0.5 mg / ml, only 33% or more of hemolytic activity was observed in the ethanol extract and its ethyl acetate fraction in the crude oil seed samples, indicating potential toxicity. Other samples showed no hemolytic activity.
에탄올 추출물
(0.5 mg/ml)Corn seed oil
Ethanol extract
(0.5 mg / ml)
열수 추출물
(0.5 mg/ml)Corn seed oil
Hot water extract
(0.5 mg / ml)
상기의 결과들을 종합할 때, 산수유 종자의 에탄올 추출물 및 열수 추출물의 경우 강력한 항산화 활성을 나타내며, 이들 추출물의 유기용매 분획물의 경우, 에탄올 추출물의 헥센 분획을 제외한 모든 분획물에서 매우 강력한 항산화 활성을 나타내므로, 산수유 종자의 다양한 용매 추출물 및 분획물은 산화적 스트레스 예방 및 치료용으로 사용할 수 있는 뛰어난 효과가 있으며, 이를 포함하는 조성물은 화장품 산업, 식품산업 및 제약산업의 산화적 스트레스 관련 질환의 예방 및 치료용 소재로 사용 가능하다. When the above results are summarized, the ethanol extract and hot water extract of corn oil seeds showed strong antioxidative activity, and the organic solvent fraction of these extracts showed a very strong antioxidative activity in all fractions except the hexane fraction of the ethanol extract , And various solvent extracts and fractions of marine oil seeds have excellent effects that can be used for prevention and treatment of oxidative stress. The composition containing the same is useful for the prevention and treatment of oxidative stress related diseases in the cosmetics industry, food industry and pharmaceutical industry Can be used as material.
4. 산수유 종자 활성물질의 안정성4. Stability of seed oil seed active material
상기 실시예의 산수유 종자 에탄올 추출물 및 열수 추출물을 각각 100℃에서 1시간 처리, pH 2(0.01M HCl)에서의 2시간 처리, 혈장에서 2시간 처리 후 잔존 항산화력을 측정한 결과, 상기의 처리시에 모두 초기 활성을 유지함을 확인하여, 상기 추출물의 항산화 활성 성분들이 산, 열, 및 혈장 처리시 높은 안정성을 나타냄을 확인하였다(결과 미제시). The crude extracts of the crude oil seed oil and hot-water extract of the above-mentioned Example were treated at 100 ° C for 1 hour, 2 hours at pH 2 (0.01M HCl), and 2 hours at the plasma, respectively. , It was confirmed that the antioxidant active ingredients of the extract showed high stability in acid, heat, and plasma treatment (no result).
실시예Example 2 2
1. 산수유 잎의 다양한 용매 추출1. Various solvent extraction of corn oil leaves
경북 의성에서 2011년 10~11월 산수유 잎을 채취한 후 흐르는 물에 수세하여 이물질을 제거하고, 이를 7일간 음건한 후, 100메쉬로 분쇄한 후 추출에 사용하였다. 추출용매로는 열수 및 에탄올(95%)을 사용하였으며, 분쇄 잎 무게 대비 10배의 유기용매를 가한 후 상온에서 24시간씩 3회 추출하거나, 10배의 열수를 가한 후 100℃에서 30분간 추출하였다. 추출물은 감압 농축하여 분말로 제조하였으며, 사용 전까지 저온 밀봉 보관하였다. 조제된 산수유 잎 추출물의 총 플라보노이드(total flavonoid) 및 총 폴리페놀(total polyphenol) 함량, 총당 및 환원당 함량을 측정하였으며, 총 플라보노이드 함량의 표준품으로는 rutin, 총 폴리페놀 함량의 표준품으로 tannic acid을 사용하였다. 환원당은 DNS법으로, 총당은 phenol-sulfuric acid법을 이용하여 정량하였다. 각각의 추출물의 추출효율 및 성분 분석결과는 표 5에 나타내었으며, 열수 추출의 경우가 에탄올 추출보다 약 2배의 추출효율이 높게 나타났다. 열수 추출물의 분획의 경우 유기용매 분획 후 물 잔류물이 추출물 대비 47.9%를 차지하였으나, 에탄올 추출물의 분획의 경우 유기용매 분획 후 물 잔류물이 추출물 대비 13.0%를 차지하여 추출용매에 따른 물질 특성이 다름을 알 수 있었다. 성분 분석 결과 추출물에서의 가장 큰 차이는 폴리페놀 함량에서 나타났으며, 에탄올 추출물보다 열수 추출물이 약 2.2배 이상 높은 함량을 나타내었다. 열수 추출물의 에틸아세테이트 분획물의 경우, 분획수율은 7.3%로 낮은 반면 489mg/g 및 60.4mg/g의 매우 높은 폴리페놀 및 플라보노이드 함량을 나타내었으며, 이러한 함량은 에틸아세테이트 > 부탄올 > 물 잔류물 > 헥센 분획 순으로 나타났다. 산수유 잎의 에탄올 추출물의 경우에도 에틸아세테이트 분획에서 높은 폴리페놀 및 플라보노이드 함량을 나타내었으나, 폴리페놀의 경우 에탄올 추출물의 용매분획 후의 물 잔류물(178.95mg/g)이 에틸아세테이트(129.78mg/g)보다 높게 나타났다. 따라서, 폴리페놀 함량의 경우, 물 잔류물 > 에틸아세테이트 > 부탄올 > 헥센 분획 순, 플라보노이드 함량의 경우 에틸아세테이트 > 부탄올 > 물 잔류물 > 헥센 분획 순으로 나타났다. 이러한 결과는 산수유 잎이 수용성 폴리페놀을 고농도로 함유하고 있으며, 지용성 폴리페놀성분도 상당량 가지고 있음을 의미한다. 일반적으로 천연물의 항균 활성이 폴리페놀 및 플라보노이드 성분에 기인함을 고려할 때, 산수유 잎의 매우 높은 폴리페놀 및 플라보노이드 함량은 강력한 항균 활성과 관련되리라 판단되었다.In October ~ November 2011, leaves of corn oil were collected from Gyeongsangbuk-do, Gyeongsangbuk-do Province, and the water was washed with water to remove foreign matter. After shaking for 7 days, it was crushed into 100 mesh and used for extraction. The extraction solvent used was hot water and ethanol (95%). After 10 times as much organic solvent as the weight of the crushed leaf, it was extracted 3 times at room temperature for 24 hours or 10 times of hot water, Respectively. The extract was concentrated under reduced pressure to give a powder, which was stored at low temperature until use. Total flavonoid, total polyphenol, total sugar, and reducing sugar content of the prepared extracts were measured. As the standard of total flavonoid content, rutin and tannic acid were used as the standard of total polyphenol content. Respectively. Reducing sugar was determined by DNS method and total sugar was quantified by phenol-sulfuric acid method. The extraction efficiency and component analysis results of each extract are shown in Table 5. The extraction efficiency of hot water extraction was about twice as high as that of ethanol extraction. In the case of the fraction of the hot water extract, the water residue after the fractionation of organic solvent accounted for 47.9% of the extract, whereas the fraction of the ethanol extract accounted for 13.0% of the water residue after the fractionation of the organic solvent, I could see the difference. The major difference in the extracts was found in the content of polyphenol, and the content of hot - water extract was 2.2 times higher than that of ethanol extract. In the case of the ethyl acetate fraction of the hot water extract, fractional yields were as low as 7.3%, while very high polyphenol and flavonoid contents of 489 mg / g and 60.4 mg / g were obtained. Ethyl acetate> butanol> water residues> Respectively. In the case of polyphenol, the water residue (178.95 mg / g) after the solvent fractionation of the ethanol extract was higher than that of ethyl acetate (129.78 mg / g) in the ethyl acetate fraction, Respectively. Therefore, in the case of polyphenol content, ethyl acetate> butanol> hexene fraction in order of water residues, ethyl acetate> butanol> water residue> hexene fraction in order of flavonoid content. These results indicate that the acidophilus leaves contain a high concentration of water-soluble polyphenols and a large amount of fat-soluble polyphenols. Considering that the antimicrobial activity of natural products is generally attributed to polyphenols and flavonoids, very high levels of polyphenols and flavonoids in the leaves of corn oil were thought to be associated with strong antimicrobial activity.
용매extraction
menstruum
분획율(%)Extraction rate /
Fraction (%)
(100℃)Heat number
(100 DEG C)
2. 산수유 잎 추출물 및 2. Corn oil leaf extract and 분획물의Fraction 항균 활성 Antimicrobial activity
조제된 산수유 잎 추출물 및 분획물을 이용하여 항균 활성을 평가하였으며, 그람 음성균으로 Escherichia coli KCTC 1682, Proteus vulgaris KCTC 2433, Salmonella typhimurium KCTC 1926을 사용하였고, 그람 양성균으로는 Staphylococcus aureus KCTC 1916, Listeria monocytogenes KACC 10550, Bacillus subtilis KCTC 1924를 사용하였다. 한편, 항진균 활성 평가를 위해서는 Saccharomyces cerevisiae IF0 0233 및 캔디다증 진균감염증 원인균 Candida albicans KCTC 1940을 사용하였다. Escherichia coli KCTC 1682, Proteus vulgaris KCTC 2433 and Salmonella typhimurium KCTC 1926 were used as Gram negative bacteria. Staphylococcus aureus KCTC 1916 and Listeria monocytogenes KACC 10550 were used as Gram positive bacteria. , Bacillus subtilis KCTC 1924 were used. Saccharomyces cerevisiae IF0 0233 and Candida albicans KCTC 1940, the causative agent of fungus infections, were used for evaluation of antifungal activity.
먼저, 항세균 활성 평가의 경우, Nutrient broth(Difco Co., USA)에 각각의 세균을 접종하여 37℃에서 24시간 동안 배양한 후, 각 균주를 O.D.600 0.1로 조정하여 Nutrient agar(Difco Co., USA) 배지를 포함하는 멸균 petri dish(9015mm, 녹십자, 한국)에 100μl씩 도말하고, 각각의 시료 5μl를 멸균 disc-paper(지름 6.5mm, Whatsman No. 2)에 가하여, 37℃에서 24시간 동안 배양하였으며, 진균의 경우에는 Sabouraud dextrose(Difco Co. USA)를 이용하여 동일한 방법으로 30℃에서 24시간 동안 배양 후, 생육저지환의 크기를 측정하여 항균활성을 평가하였다. 대조구로는 항세균제인 엠피실린(ampicillin)과 항진균제인 마이코나졸(miconazole, Sigma Co., USA)을 각각 1g/disc 농도로 사용하였으며, 생육저지환의 크기는 육안으로 생육이 나타나지 않는 부분의 지름을 mm 단위로 측정하였고, 3회 이상 평가 후 대표 결과로 표 6에 나타내었다.First, the case wherein the bacterial activity evaluation, Nutrient broth (Difco Co., USA) and then inoculated to each of the bacteria were cultured at 37 ℃ for 24 hours, by adjusting the respective strain to OD 600 0.1 Nutrient agar (Difco Co. (Diameter 6.5mm, Whatsman No. 2) was added to each well of a sterilized petri dish (9015 mm, Green Cross, Korea) containing the medium . In the case of fungi, Sabouraud dextrose (Difco Co., USA) was cultured in the same manner at 30 ° C for 24 hours, and the size of the growth inhibition rings was measured to evaluate the antimicrobial activity. As control, ampicillin, an antimicrobial agent, and miconazole (Sigma Co., USA), an antifungal agent, were used at a concentration of 1 g / disc, respectively. The size of the growth inhibition ring was determined by the naked eye mm, and is shown in Table 6 as representative results after three or more evaluations.
(1 g/disc) Antibiotic
(1 g / disc)
(500 μg/disc)Corn oil leaves ethanol extract
(500 μg / disc)
(500 μg/disc)Hot water extract of corn oil leaves
(500 μg / disc)
실린MP
Syllable
아세테이트 분획물 ethyl
Acetate fraction
잔류물water
Residue
아세테이트 분획물 ethyl
Acetate fraction
잔류물water
Residue
세균Gram negative
Germ
세균Gram positive
Germ
ECEC : : EscherichiaEscherichia colicoli , ,
PVPV : : ProteusProteus vulgarisvulgaris , ,
STST : : SalmonellaSalmonella typhimuriumtyphimurium , ,
SASA : : StaphylococcusStaphylococcus aureusaureus , ,
LMLM : : ListeriaListeria monocytogenesmonocytogenes , ,
BSBS : : BacillusBacillus subtilissubtilis , ,
SCSC : : SaccharomycesSaccharomyces cerevisiaecerevisiae , ,
CACA : : CandidaCandida albicansalbicans . .
-: 생육저해 없음. -: No growth inhibition.
표 6에 나타낸 바와 같이, 항세균 활성대조구로 사용된 엠피실린(1g/disc)의 경우 10.0~36.0mm의 생육억제환을 나타내어 강력한 항세균 활성을 확인하였으며, 항진균제인 마이코나졸(1g/disc)의 경우 C. albicans에 대해 28mm의 생육억제환을 나타내었다. 산수유 잎 추출물의 경우, 에탄올 추출물(500g/disc)은 그람양성세균에서만 항균력을 나타내었으며, 열수 추출물(500g/disc)은 그람 양성, 음성 세균 및 진균에 대해 항균력이 나타나지 않았다. 그러나 에탄올 추출물의 분획물의 경우, 물 잔류물을 제외한 헥센, 에틸아세테이트, 부탄올 분획물에서 그람 음성세균 및 그람 양성세균 모두에 대해 광범위 항균 활성을 나타내었으며, 특히 헥센 및 에틸아세테이트 분획에서 우수한 항균 활성이 나타났다. 반면 열수 추출물의 경우 추출물에서는 항균 활성이 나타나지 않았으나, 헥센 및 에틸아세테이트 분획에서 강력한 광범위 항균 활성이 확인되었다. 따라서, 산수유 잎의 에탄올 및 열수 추출물의 헥센 및 에틸아세테이트 분획이 강력한 항균 활성을 나타내어, 이들 분획물을 포함하는 세균 감염 예방 및 치료용 조성물로 개발 가능함을 확인하였다. As shown in Table 6, the strong antifungal activity of amphylline (1 g / disc) used as an anti-bacterial activity control was confirmed to be 10.0 ~ 36.0 mm, The growth inhibition ring was 28 mm against C. albicans . The ethanol extract (500 g / disc) showed antimicrobial activity only against Gram - positive bacteria, whereas the hydrothermal extract (500 g / disc) showed no antimicrobial activity against Gram - positive, negative bacteria and fungi. However, the fraction of ethanol extract showed broad antimicrobial activity against gram negative bacteria and gram positive bacteria in the hexene, ethyl acetate and butanol fractions except the water residue, and especially the hexene and ethyl acetate fractions showed excellent antimicrobial activity . On the other hand, hydrothermal extract did not show antimicrobial activity in the extract, but strong broad antimicrobial activity was confirmed in the hexene and ethyl acetate fractions. Therefore, it was confirmed that the hexane and ethyl acetate fractions of the ethanol extract and hot water extract of the corn oil leaves exhibit a strong antimicrobial activity, and that it can be developed as a composition for prevention and treatment of bacterial infection including these fractions.
3. 산수유 잎 추출물 및 3. Corn oil leaf extract and 분획물의Fraction 인간 적혈구 Human red blood cells 용혈활성Hemolytic activity
산수유 잎 추출물 및 분획물의 적혈구 용혈활성을 평가한 결과는 표 7에 나타내었다. 먼저, 대조구로 사용된 DMSO와 증류수는 용혈활성이 없었으며, triton X-100은 0.1% 농도에서 적혈구를 100% 용혈시킴을 확인하였다. 0.5mg/ml 농도에서, 산수유 잎 시료 중에서는 에탄올 추출물만이 17.2%의 미약한 용혈활성을 나타내었으며, 그 외의 시료는 용혈 활성이 거의 나타나지 않았다.Table 7 shows the results of evaluating the erythrocyte hemolytic activity of the extracts and fractions of corn oil. First, DMSO and distilled water used as a control had no hemolytic activity, and triton X-100 was found to hemolyze red blood cells at a concentration of 0.1%. At 0.5 mg / ml concentration, ethanol extract alone showed 17.2% hemolytic activity in leaves of corn oil, and other samples showed little hemolytic activity.
에탄올 추출물
(0.5 mg/ml)Leaves of corn oil
Ethanol extract
(0.5 mg / ml)
열수 추출물
(0.5 mg/ml)Leaves of corn oil
Hot water extract
(0.5 mg / ml)
따라서, 상기의 결과들을 종합할 때, 산수유 잎의 에탄올 추출물 및 열수 추출물은 다양한 항산화 활성물질을 함유하고 있으며, 특히 산수유 잎의 에탄올 및 열수 추출물의 에틸아세테이트 분획물은 별도의 적혈구 용혈 활성과 같은 부작용을 나타내지 않으면서 강력한 항산화 활성을 동시에 나타내어 산화적 스트레스와 관련된 질환의 예방 및 치료용으로 사용할 수 있는 뛰어난 효과가 있음을 확인하였다.Therefore, when the above results are summarized, the ethanol extract and hot water extract of corn oil leaves contain various antioxidant active substances. Particularly, ethanol and hot water extract of the corn oil leaves have side effects such as erythrocyte hemolytic activity And exhibits a strong antioxidative activity at the same time, thus showing an excellent effect that can be used for prevention and treatment of diseases related to oxidative stress.
4. 산수유 잎 활성물질의 안정성4. Stability of Active Ingredients of Acanthopanax oleic Acid
산수유 잎 에탄올 추출물 및 열수 추출물의 에틸아세테이트 분획물을 각각 100℃에서 1시간 처리, pH 2(0.01M HCl)에서의 2시간 처리, 혈장에서 2시간 처리 후 잔존 항산화력을 측정한 결과, 상기의 처리시에 모두 초기 활성을 유지함을 확인하여, 상기 추출물의 항산화 활성 성분들이 산, 열, 및 혈장 처리시 높은 안정성을 나타냄을 확인하였다(결과 미제시).The antioxidant activity of the extracts of the leaves of the leaves of corn oil and the ethylacetate fractions of the hot-water extract were measured at 100 ° C for 1 hour, 2 hours at pH 2 (0.01M HCl) and 2 hours at the plasma, It was confirmed that the antioxidant active ingredients of the extract showed high stability in acid, heat, and plasma treatment (no result).
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140028383A KR101602552B1 (en) | 2014-03-11 | 2014-03-11 | Antimicrobial composition comprising the extract of cornus officinalis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140028383A KR101602552B1 (en) | 2014-03-11 | 2014-03-11 | Antimicrobial composition comprising the extract of cornus officinalis |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150106191A KR20150106191A (en) | 2015-09-21 |
KR101602552B1 true KR101602552B1 (en) | 2016-03-10 |
Family
ID=54245137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140028383A KR101602552B1 (en) | 2014-03-11 | 2014-03-11 | Antimicrobial composition comprising the extract of cornus officinalis |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101602552B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102079191B1 (en) | 2018-09-04 | 2020-02-19 | 코스원 주식회사 | Natural antimicrobial compositions and cosmetics containing them |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102012000B1 (en) * | 2018-01-16 | 2019-08-19 | 김경희 | Coating composition for infection control of tattoo area and method of preparing the same |
KR101940627B1 (en) * | 2018-10-12 | 2019-01-21 | 정나호 | Manufacturing method of feed for pet dog |
CN111012817A (en) * | 2019-12-05 | 2020-04-17 | 河南科技学院 | Preparation method and application of dogwood seed extract |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101358203B1 (en) * | 2011-11-25 | 2014-02-06 | 안동대학교 산학협력단 | Composition comprising the extract of Cornus officinalis for prevention or control of thrombosis |
-
2014
- 2014-03-11 KR KR1020140028383A patent/KR101602552B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102079191B1 (en) | 2018-09-04 | 2020-02-19 | 코스원 주식회사 | Natural antimicrobial compositions and cosmetics containing them |
Also Published As
Publication number | Publication date |
---|---|
KR20150106191A (en) | 2015-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20200003993A (en) | Antimicrobial composition comprising the leaf extract of polygonium ticnctorium and use thereof | |
KR101791549B1 (en) | An antibacterial composition comprising the pachyrhizus erosus root bark extract as an effective component | |
KR101715622B1 (en) | Antimicrobial composition comprising the extraction of suaeda spp as an effective component | |
KR101602552B1 (en) | Antimicrobial composition comprising the extract of cornus officinalis | |
KR102243591B1 (en) | Antimicrobial composition comprising the extract of rodgersia podophylla | |
KR101467698B1 (en) | Anti-microbial composition comprising cynanchi wilfordii radix extract and the use thereof | |
KR101806720B1 (en) | Antibacterial-listeria composition of culture medium containing membranous milkvetch root fermented with lactobacillus plantarum | |
KR102086166B1 (en) | Antimicrobial composition comprising the extracts of rambutan peel | |
KR101976201B1 (en) | Antimicrobial composition comprising the sprout extract of zingiber officinale | |
KR101911847B1 (en) | Antimicrobial composition comprising organic solvent fractions of arctium lappa root extracts as an effective component | |
KR101776511B1 (en) | Antibacterial-listeria composition of culture medium containing chinese juniper berries fermented with lactobacillus plantarum | |
KR102254424B1 (en) | Antimicrobial composition comprising the extract of sageretia thea | |
KR101636608B1 (en) | Composition for antioxidation comprising the seed extract of cornus officinalis | |
KR20220094308A (en) | Pharmaceutical composition for preventing or treating infectious symptoms by pathogenic microorganism comprising Cichorium intybus extract as an active ingredient | |
KR20200058353A (en) | Antimicrobial composition comprising the hexane and butanol fractions of teleogryllus emma extract | |
KR102287389B1 (en) | Antimicrobial composition comprising the extract of flower bud of panax ginseng c. a. meyer | |
KR102254425B1 (en) | Antimicrobial composition comprising the extract of immature fruit extract of magnolia denudata | |
KR102287391B1 (en) | Antimicrobial composition comprising the extract of moringa root | |
KR102534868B1 (en) | Antimicrobial composition comprising the extract from coccon of protaetia brevitarsis | |
KR102677601B1 (en) | Antimicrobial composition comprising the kenaf seed extract of jang-dae cultivar | |
KR102572181B1 (en) | Antimicrobial composition comprising the extract from wasp | |
KR20240048145A (en) | Antimicrobial composition comprising the extract of songhwa mushroom fruiting body | |
KR102669103B1 (en) | Antimicrobial composition comprising the micro scaled powder of bast fiber of cannabis sativa l. | |
KR102131454B1 (en) | Antimicrobial composition comprising the extract of yunnongchamssal | |
KR20220053247A (en) | Antimicrobial composition comprising the ethyl acetate fraction of aerial part of glehnia littoralis extract as an effective component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20190304 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20200102 Year of fee payment: 5 |